Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Myelin-specific Th17 cells induce severe relapsing optic neuritis with irreversible loss of retinal ganglion cells in C57BL/6 mice.
EU regulator warns on possible MS drugs side effects
Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator.
Dimethyl fumarate (BG-12, Tecfidera) - NICE says yes in draft final guidance
Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing MS.
Multiple sclerosis in 2014: Progress in MS-classification, mechanisms and treatment.
Cost-effectiveness analysis of peginterferon beta-1a compared with interferon beta-1a and glatiramer acetate in the treatment of relapsing-remitting multiple sclerosis in the United States.
Mitoxantrone: benefits and risks in multiple sclerosis patients.
Individualized quality of life of severely affected multiple sclerosis patients: practicability and value in comparison with standard inventories.
Ethnicity and prevalence of multiple sclerosis in east London.
Infectious mononucleosis at the United States Military Academy. A prospective study of a single class over four years.
Genpharm and Genzyme Aubagio ® agreement for the MENA region
Protective effects of monomethyl fumarate at the inflamed blood-brain barrier.
Tolerability and Pulmonary Pharmacodynamic Effects During Treatment Initiation of Once-Daily Oral Fingolimod in Subjects With Moderate Asthma.
Current and future immunotherapy targets in autoimmune neurology.
Headache in relapse and remission phases of multiple sclerosis: A case-control study.
Radiologically isolated syndrome: 5-year risk for an initial clinical event.
Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis: a prospective, non-randomized pilot study.
Persistency of neutralizing antibodies depends on titer and interferon-beta preparation.
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.
Copaxone
Interferon-beta is a potent promoter of nerve growth factor production by astrocytes.
Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review.
Allelic combinations of immune-response genes associated with glatiramer acetate treatment response in Russian multiple sclerosis patients.
Optical coherence tomography and neurodegeneration: are eyes the windows to the brain?

Pages